ロード中...
Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain
BACKGROUND: Aminoglycosides such as amikacin and kanamycin are effective injectable second-line drugs for treatment of multidrug-resistant tuberculosis. Molecular mechanisms underlying aminoglycoside resistance are not well understood. We have previously identified the amikacin- and kanamycin-resist...
保存先:
| 出版年: | Ann Clin Microbiol Antimicrob |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047124/ https://ncbi.nlm.nih.gov/pubmed/30008266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0285-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|